Fredy Geiger

Mr. Fredy Geiger

Department of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland
+1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
FGFredy Geiger
Fredy Geiger
SSSadiq Said
Sadiq Said
ABAnahita Bajka
Anahita Bajka
Mario Damiano ToroMario Damiano Toro
Mario Damiano Toro
MWMaximilian Robert Justus Wiest
Maximilian Robert Justus Wiest
SZSandrine Anne Zweifel
Sandrine Anne Zweifel
Using multimodal imaging, the literature proposed the following risk factors for choroidal nevus growth into melanoma: increased tumor thickness, subretinal fluid, decreased visual acuity, presence of orange pigment, ultrasound acoustic hollowness, and increased tumor diameter. This study investigated the presence of the mentioned risk factors in choroidal nevi, choroidal melanomas, and indeterminate choroidal melanocytic lesions. This retrospective, single-center chart review assessed choroidal melanocytic tumors with multimodal imaging. We defined our primary outcome as the cumulative presence of mentioned risk factors. Further, we evaluated various optical coherence tomography (OCT), ultrasound, and autofluorescence findings. We analyzed 51 tumors from 49 patients during the period from April 2008 to June 2021. The median (IQR) age was 64.0 (56.0 to 70.5) years, with 23 of 49 (46.9%) patients being female. The follow-up time for all tumors was median (IQR) 25.0 (12.0 to 39.0) months. The choroidal nevi had a median (range) risk score of 0.0 (0.0 to 3.0), and the choroidal melanoma of 5.0 (3.0 to 6.0), with statistically significant different ratings (p < 0.001). Multimodal imaging creates a score that may help to distinguish choroidal nevi from choroidal melanomas objectively.

4 February 2026 in Klinische Monatsblätter für Augenheilkunde
Verified
Journal Article
Open access
PDF file
FGFredy Geiger
Fredy Geiger
ASAlexandra Steinemann-Inauen
Alexandra Steinemann-Inauen
PMPeter Meyer
Peter Meyer
Amyloidosis refers to a heterogeneous group of disorders characterized by the deposition of insoluble protein fibrils in various tissues, including the eyes and their adnexa. It can occur either systemically or locally and is classified based on the type of amyloid protein involved. To date, 42 different amyloid fibril proteins have been identified; however, not all are associated with ocular deposition [1]. Orbital and adnexal amyloidosis is rare and most commonly affects the eyelid, orbit, and conjunctiva. While it can be the initial manifestation of systemic involvement, most cases are localized with amyloid light-chain (AL) deposits being the most common, resulting from the accumulation of misfolded immunoglobulin light chains [2], [3]. Due to the heterogeneity of the disease and the limited literature available, the diagnosis and management of orbital and adnexal amyloidosis remain challenging. Received: 06 October 2025 Accepted: 02 December 2025 Article published online: 04 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 14, 70469 Stuttgart, Germany